Literature DB >> 12972464

A role for leptin in rheumatic diseases?

G Palmer1, C Gabay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12972464      PMCID： PMC1754337          DOI： 10.1136/ard.62.10.913

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  30 in total

1.  Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis.

Authors:  Nathalie Busso; Alexander So; Véronique Chobaz-Péclat; Carole Morard; Eduardo Martinez-Soria; Dominique Talabot-Ayer; Cem Gabay
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

2.  Requirement for leptin in the induction and progression of autoimmune encephalomyelitis.

Authors:  G Matarese; A Di Giacomo; V Sanna; G M Lord; J K Howard; A Di Tuoro; S R Bloom; R I Lechler; S Zappacosta; S Fontana
Journal:  J Immunol       Date:  2001-05-15       Impact factor: 5.422

3.  Leptin consumption in the inflamed joints of patients with rheumatoid arthritis.

Authors:  M Bokarewa; D Bokarew; O Hultgren; A Tarkowski
Journal:  Ann Rheum Dis       Date:  2003-10       Impact factor: 19.103

4.  Serum leptin concentration is increased in patients with Behçet's syndrome and is correlated with disease activity.

Authors:  C Evereklioglu; H S Inalöz; N Kirtak; S Doganay; M Bülbül; E Ozerol; H Er; E Ozbek
Journal:  Br J Dermatol       Date:  2002-08       Impact factor: 9.302

5.  Serum leptin levels in women with systemic lupus erythematosus.

Authors:  Araceli Garcia-Gonzalez; Laura Gonzalez-Lopez; Isela C Valera-Gonzalez; Ernesto G Cardona-Muñoz; Mario Salazar-Paramo; Manuel González-Ortiz; Esperanza Martínez-Abundis; Jorge I Gamez-Nava
Journal:  Rheumatol Int       Date:  2002-06-27       Impact factor: 2.631

6.  Immune response in the mutant diabetic C57BL/Ks-dt+ mouse. Discrepancies between in vitro and in vivo immunological assays.

Authors:  G Fernandes; B S Handwerger; E J Yunis; D M Brown
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

7.  Cell-mediated immunity in genetically obese C57BL/6J ob/ob) mice.

Authors:  R K Chandra
Journal:  Am J Clin Nutr       Date:  1980-01       Impact factor: 7.045

8.  High-dose leptin activates human leukocytes via receptor expression on monocytes.

Authors:  H Zarkesh-Esfahani; G Pockley; R A Metcalfe; M Bidlingmaier; Z Wu; A Ajami; A P Weetman; C J Strasburger; R J Ross
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

9.  Leptin in septic arthritis: decreased levels during infection and amelioration of disease activity upon its administration.

Authors:  O H Hultgren; A Tarkowski
Journal:  Arthritis Res       Date:  2001-09-19

10.  Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency.

Authors:  I Sadaf Farooqi; Giuseppe Matarese; Graham M Lord; Julia M Keogh; Elizabeth Lawrence; Chizo Agwu; Veronica Sanna; Susan A Jebb; Francesco Perna; Silvia Fontana; Robert I Lechler; Alex M DePaoli; Stephen O'Rahilly
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808
View more
  23 in total

1.  Immunometabolic biomarkers of inflammation in Behçet's disease: relationship with epidemiological profile, disease activity and therapeutic regimens.

Authors:  L Cantarini; V Pucino; A Vitale; R Talarico; O M Lucherini; F Magnotti; V De Rosa; M Galgani; C Alviggi; G Marone; M Galeazzi; G Matarese
Journal:  Clin Exp Immunol       Date:  2016-02-24       Impact factor: 4.330

2.  Role of leptin in autoimmune diseases.

Authors:  Manole Cojocaru; Inimioara Mihaela Cojocaru; Isabela Siloşi; Suzana Rogoz
Journal:  Maedica (Bucur)       Date:  2013-03

Review 3.  [Adipocytokines as driving forces in rheumatoid arthritis].

Authors:  E Neumann; A Knedla; F Meier; I H Tarner; C Büchler; A Schäffler; U Müller-Ladner
Journal:  Z Rheumatol       Date:  2007-03       Impact factor: 1.372

Review 4.  Adipokines in bone disease.

Authors:  Elena Neumann; Susann Junker; Georg Schett; Klaus Frommer; Ulf Müller-Ladner
Journal:  Nat Rev Rheumatol       Date:  2016-04-15       Impact factor: 20.543

5.  Protective effect of soy protein on collagen-induced arthritis in rat.

Authors:  Majid Mohammad Shahi; Mohammad-Reza Rashidi; Soltanali Mahboob; Fatemeh Haidari; Bahman Rashidi; Jalal Hanaee
Journal:  Rheumatol Int       Date:  2011-06-17       Impact factor: 2.631

6.  Body composition, insulin, and leptin levels in patients with ankylosing spondylitis.

Authors:  Ismail Sari; Tevfik Demir; Leyla Didem Kozaci; Servet Akar; Tulay Kavak; Merih Birlik; Fatos Onen; Nurullah Akkoc
Journal:  Clin Rheumatol       Date:  2007-01-27       Impact factor: 2.980

7.  Role and regulation of adipokines during zymosan-induced peritoneal inflammation in mice.

Authors:  Maria Pini; Melissa E Gove; Joseph A Sennello; Jantine W P M van Baal; Lawrence Chan; Giamila Fantuzzi
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

8.  Comparison of the effects of genistein and daidzein with dexamethasone and soy protein on rheumatoid arthritis in rats.

Authors:  Majid Mohammad-Shahi; Fatemeh Haidari; Bahman Rashidi; Amir Ata Saei; Soltanali Mahboob; Mohammad-Reza Rashidi
Journal:  Bioimpacts       Date:  2011-09-30

9.  Leptin serum levels in rheumatoid arthritis patients: relation to disease duration and activity.

Authors:  Bozena Targońska-Stepniak; Maria Majdan; Magdalena Dryglewska
Journal:  Rheumatol Int       Date:  2007-10-30       Impact factor: 2.631

10.  Serum leptin in systemic lupus erythematosus.

Authors:  M Wisłowska; M Rok; K Stepień; A Kuklo-Kowalska
Journal:  Rheumatol Int       Date:  2008-01-15       Impact factor: 2.631
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.